BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 16, 2020
View Archived Issues
IRDye800CW-nimotuzumab enters phase I/II study for image-guided lung cancer surgery
Read More
Q32 Bio begins phase I study with ADX-914 in healthy volunteers
Read More
Regeneron initiates phase I study of NPR1 agonist REGN-5381
Read More
Prion protein's positive point
Read More
"Fight or flight" nervous system helps fight tumors, too
Read More
Preliminary results support ongoing development of Biogen's BTK inhibitor
Read More
Dosing starts in phase I study of exoIL-12
Read More
EMA approves label update for HyQvia
Read More
Arbutus presents continued positive data from first-in-human study of AB-729
Read More
SAB-402, a novel potent dual EGFR/HER4 tyrosine kinase inhibitor with promising activity in vivo
Read More
Specific PAC1 receptor antibody as potential new treatment of primary headaches
Read More
RNA-targeted CRISPR reverses myotonic dystrophy symptoms
Read More
Bioardis divulges new FGFR4 inhibitors
Read More
C4 Therapeutics patents new CRBN-targeting compounds
Read More
Bristol-Myers Squibb identifies TYK2 inhibitors
Read More
FDA clears IND for bispecific antibody EMB-02 for solid tumors
Read More
AC Immune identifies new MAPT aggregation inhibitors
Read More
Sec61 protein secretion-interfering compounds presented by Kezar Life Sciences
Read More
New animal model created to study cerebellar dysfunction in multiple sclerosis
Read More
Phase III trial of ganaxolone in CDKL5 deficiency disorder meets primary endpoint
Read More
AQP4 and Cx43 expression alteration leads to neuromyelitis optica
Read More
Escient initiates phase I/Ib study of EP-547 to treat cholestatic and uremic pruritus
Read More
New preclinical data reported on ICON-2 for solid tumors
Read More
Grant supports Melior's evaluation of tolimidone for COVID-19
Read More
Innovation Pharmaceuticals reports new in vitro data on use of brilacidin for COVID-19
Read More
Lilly reports interim phase II data on SARS-CoV-2 neutralizing antibody LY-CoV555
Read More